What industrial processes generate phosgene (COCl₂), why is it so dangerous despite its low IDLH of 2 ppm, and what is the symptom-free interval mechanism?

Phosgene (COCl₂, carbonyl chloride, CAS 75-44-5) is one of the most insidiously dangerous industrial gases because it combines a very low IDLH (2 ppm — among the lowest of industrial gases), low odor warning at hazardous concentrations, and a characteristic delayed clinical presentation that leads exposed workers to believe they are uninjured. Physical and chemical properties: Phosgene is a colorless gas at standard temperature and pressure (bp −7.6°C; at room temperature, pure phosgene is a gas). It has a characteristic odor described as freshly cut hay, freshly mown grass, or 'green corn' — an odor that many workers find mildly pleasant or non-alarming. Critically, phosgene can be odorless at low concentrations (detection threshold ~0.5–1 ppm) and its odor becomes faint and deceptive relative to its toxicity. At the IDLH of 2 ppm, most workers detect only a faint, somewhat pleasant odor — not the alarm signal that more obvious irritants like ammonia or chlorine provide. Phosgene is 3.4× denser than air (density ≈ 4.2 g/L) and accumulates in low points. Industrial sources of phosgene: 1. TDI (toluene diisocyanate) and MDI (methylene diphenyl diisocyanate) thermal decomposition: isocyanates (–N=C=O functional group) decompose to phosgene at temperatures above 200–300°C. TDI/MDI fires, hot-work in isocyanate-coated structures, or thermal cutting/welding of polyurethane foam (insulation, automotive seating) produce phosgene as a primary decomposition product. This is the most important industrial phosgene source in modern workplaces. 2. Chlorinated solvent combustion: chlorinated hydrocarbon solvents (chloroform CHCl₃, carbon tetrachloride CCl₄, methylene chloride DCM CH₂Cl₂, trichloroethylene TCE, perchloroethylene PCE) oxidize to phosgene when heated above their decomposition temperature or exposed to flame. Welding near degreased metal surfaces, cutting chlorinated plastic, or fires involving chlorinated solvents produce phosgene. This is a recognized hazard in metalworking and degreasing operations. 3. Chlorinated plastic combustion: PVC (polyvinyl chloride), chlorinated polyethylene, chloroprene rubber, and other chlorinated polymers generate phosgene when they burn, in addition to HCl gas. 4. Chemical synthesis: phosgene is an industrial chemical intermediate (production ~3 million tons/year) used in polycarbonate plastic, agricultural chemicals, and pharmaceutical synthesis; it is generated on-site and consumed immediately. 5. Carbon monoxide + chlorine: the industrial synthesis reaction (CO + Cl₂ → COCl₂, catalyzed by activated carbon) also occurs adventitiously in chlorinated industrial atmospheres containing trace CO and Cl₂. OSHA and ACGIH exposure limits: • OSHA PEL: 0.1 ppm Ceiling (29 CFR 1910.1000, Table Z-1) — a ceiling limit, not a TWA; concentration must not exceed 0.1 ppm at any time • ACGIH TLV-C: 0.1 ppm ceiling (same as OSHA PEL) • NIOSH IDLH: 2 ppm — 20× the OSHA PEL ceiling; phosgene's IDLH is very low compared to most industrial gases • NIOSH REL: 0.1 ppm Ceiling (same as OSHA) Note: the IDLH is 2 ppm, OSHA PEL ceiling is 0.1 ppm. This means the IDLH is only 20× the permissible ceiling — an unusually narrow margin. For comparison, CO has OSHA PEL 50 ppm and IDLH 1,200 ppm (24× margin); NH₃ has PEL 50 ppm and IDLH 300 ppm (6× margin). Phosgene's narrow IDLH-to-PEL ratio reflects its extreme acute pulmonary toxicity. The symptom-free interval (latency period) — why phosgene kills: Phosgene's primary target organ is the lung, specifically the alveolar-capillary interface. Phosgene's mechanism of pulmonary injury: 1. Inhalation: phosgene is poorly water-soluble (unlike chlorine or ammonia, which dissolve in upper respiratory tract moisture causing immediate irritation). Phosgene penetrates to the alveolar level with minimal upper-airway warning. 2. Alveolar hydrolysis: at the alveolar-capillary interface, phosgene hydrolyzes with tissue water: COCl₂ + H₂O → CO₂ + 2HCl. This generates HCl within alveolar tissue. 3. Acylation of proteins: beyond hydrolysis, phosgene acylates amino groups (lysine, cysteine, tyrosine, serine) in alveolar cell membranes and proteins — this carbamylation/acylation damages alveolar type I and type II pneumocytes directly. 4. Latency (4–24 hours): the initial cellular injury from acylation triggers an inflammatory cascade (neutrophil infiltration, cytokine release, capillary leak syndrome) that takes 4–24 hours to develop into clinically apparent pulmonary edema. During this latency period, the exposed worker has: • Mild eye irritation (if present) • Mild cough (if present) • No dyspnea • SpO₂ reads normal • No other symptoms The worker — and sometimes the first responder — concludes 'I was exposed but I feel fine — I must be OK.' 5. Pulmonary edema onset: after the latency period ends (typically 4–24 hours, occasionally up to 48 hours for lower exposures), capillary leak syndrome floods the alveoli with protein-rich fluid (non-cardiogenic pulmonary edema, ARDS pattern). Onset may be explosive: within minutes, the worker progresses from feeling well to severe dyspnea, cyanosis, frothy pink sputum production, and respiratory failure requiring mechanical ventilation. Exercise dramatically worsens phosgene outcome: Physical exertion during or after phosgene exposure dramatically increases pulmonary blood flow and accelerates distribution of phosgene to more alveolar surface area, and accelerates the inflammatory response. WWI experience with phosgene (responsible for ~80% of chemical warfare casualties) demonstrated clearly that soldiers who exercised or were physically active during or after exposure died faster and with higher mortality than those kept at rest. This principle remains clinically important: any worker with known or suspected phosgene exposure MUST be removed from physical activity and kept at complete rest — this is not a recommendation, it is a first-line life-saving intervention. Walking to a vehicle, climbing stairs, moving equipment — all increase mortality risk.

What is the first aid and emergency protocol for phosgene exposure, is there an antidote, and what are the first_aid_kit.* namespace fields for routing AI agents?

Phosgene first aid and emergency management: Step 1 — Rescuer protection and victim removal: Any environment where phosgene exposure has occurred must be treated as IDLH (≥2 ppm) until atmospheric monitoring confirms otherwise. Rescuers must use SCBA (APF 10,000, positive-pressure) — not APR (no activated carbon OV cartridge protects adequately at IDLH concentrations), not PAPR with acid gas cartridge (inadequate APF). Phosgene is 3.4× denser than air; it accumulates in low areas. Rescue must include lifting the victim to higher ground and removing to fresh air. Step 2 — Absolute rest: After removal from exposure, the most important first aid intervention is: COMPLETE REST. No walking. No climbing stairs. No physical exertion of any kind. The victim should be transported by stretcher or wheelchair, not ambulance-assisted walking. If the victim insists 'I feel fine, I can walk,' they must be transported recumbent regardless — exercise-induced pulmonary edema acceleration is well-documented. This principle takes priority over any other first aid consideration after victim removal. Step 3 — 100% O₂ via NRB mask: Apply supplemental O₂ (100% NRB mask, 10–15 L/min) immediately. Even during the latency period, supplemental O₂ supports the alveolar-capillary interface and may help limit early inflammatory injury. O₂ is also required as pulmonary edema develops. Step 4 — Emergency transport with 24-hour observation mandate: ALL phosgene exposures that are symptomatic OR confirmed/suspected above 0.1 ppm MUST be transported to an emergency department and admitted for minimum 24-hour observation. The hospital must be notified that the patient had phosgene exposure: the 24-hour observation period is non-negotiable because: • Pulmonary edema can develop suddenly at any point in the 4–24 hour window • SpO₂, respiratory rate, and clinical examination will appear completely normal during the latency period — normal findings do not authorize discharge • Serial chest X-rays (at 0, 6, 12, 24 hours) are required to monitor for early pulmonary edema signs before clinical decompensation • Serial spirometry (FEV1, FVC) may detect subtle functional changes before clinical symptoms Antidote status — no specific antidote exists: There is no specific antidote for phosgene poisoning. Treatment is supportive only: • Corticosteroids (IV methylprednisolone): the most debated intervention; theoretical rationale is suppression of the inflammatory cascade during the latency period; some evidence from animal models and clinical case series suggests benefit when given early (within 4 hours); NOT universally recommended; consultation with poison control center (1-800-222-1222) required before administration; some authorities do NOT recommend steroids due to lack of RCT evidence and potential for immunosuppression worsening secondary infection • Mechanical ventilation with PEEP: once pulmonary edema develops, ARDS management protocol applies; positive end-expiratory pressure (PEEP 5–15 cm H₂O) supports alveolar recruitment; low tidal volume ventilation (6 mL/kg ideal body weight) • N-acetylcysteine (NAC) IV: antioxidant; may limit lipid peroxidation in alveolar tissue; theoretical benefit; limited clinical evidence specific to phosgene • Avoid diuretics: phosgene pulmonary edema is non-cardiogenic (capillary leak); diuretics do not reduce alveolar fluid and may worsen hemodynamic instability • Do NOT use bronchodilators as primary treatment: bronchospasm is not the primary mechanism of phosgene pulmonary toxicity first_aid_kit.* namespace field definitions for phosgene routing: first_aid_kit.phosgene_source (string — tdi_mdi_combustion / chlorinated_solvent_weld / chlorinated_plastic_fire / industrial_synthesis / unknown): • 'tdi_mdi_combustion': highest risk scenario in modern workplaces; hot work on polyurethane foam, isocyanate-coated surfaces; requires specific isocyanate hot-work procedures • 'chlorinated_solvent_weld': metalworking degreasing + welding; chloroform/CCl₄/TCE/PCE oxidation to phosgene; requires isolation of degreasing area from hot-work area or confirmed atmospheric clearance before hot work • Routing consequence: source determines prevention measures (hot-work permit, atmospheric testing) co-required with first aid kit first_aid_kit.delayed_edema_risk (boolean — true / false, or string — 4_to_24_hours / onset_timing): • true: phosgene always carries delayed pulmonary edema risk; the 4–24 hour latency is a defining property of phosgene toxicity, not a variable • Routing consequence: require 24-hour observation card in kit; reject any protocol that allows discharge before 24-hour observation; flag 'symptom-free does not mean safe' warning as mandatory kit component first_aid_kit.observation_hours_required (number — minimum hospital observation hours): • 24 hours minimum for any symptomatic or confirmed phosgene exposure; some authorities recommend 48 hours for high-dose exposures • Routing consequence: AI agents must not route to 'monitor at home' or 'observe and release' protocols for phosgene exposures; hospital admission is required first_aid_kit.rest_mandatory (boolean — true): • true: always; exercise during or after phosgene exposure dramatically worsens pulmonary edema onset and severity; this is the single most important first aid instruction beyond victim removal • Routing consequence: first aid kit must include instruction card explicitly prohibiting exertion; transport-by-stretcher instruction first_aid_kit.antidote_type (string — none / o2_supportive / corticosteroid_investigational): • 'none': no FDA-approved specific antidote for phosgene; contrast with HF (calcium gluconate), CN (hydroxocobalamin), CO (O₂ ± HBO₂) • Routing consequence: AI agents must not route to antidote kits claiming specific phosgene neutralization; only supportive care is appropriate; require poison control consultation for corticosteroid decision first_aid_kit.scba_required_entry (boolean — true): • true: any entry into phosgene atmosphere requires SCBA (APF 10,000); phosgene accumulates in low points (heavy gas); activated carbon OV cartridges have very limited phosgene capacity at IDLH concentrations; SCBA is the only safe respiratory protection for rescue operations AI routing pseudocode for phosgene first aid kit: if hazard_includes 'phosgene' OR 'cocl2' OR 'carbonyl_chloride' OR 'tdi_combustion' OR 'chlorinated_solvent_fire': set delayed_edema_risk = true set observation_hours_required = 24 set rest_mandatory = true set antidote_type = 'none' set scba_required_entry = true require: O₂ NRB mask, 24-hour observation instruction card, rest/no-exertion card, poison control number flag: 'Feeling well does NOT indicate safety — phosgene edema onset is 4–24 hours after exposure' flag: 'No walking; transport by stretcher only after phosgene exposure' flag: 'ALL phosgene exposures require minimum 24-hour hospital observation regardless of symptoms' flag: 'No specific antidote — supportive care only; poison control consultation required for corticosteroid decision' reject: 'discharge before 24-hour observation' reject: 'APR or PAPR for rescue entry — SCBA required'

Namespace Library — first_aid_kit.*

Shopify First Aid Kit Schema — Phosgene COCl₂ TDI Combustion Delayed Pulmonary Edema 4–24h No Antidote SCBA Required IDLH 2 ppm, `phosgene_source` `delayed_edema_risk` `observation_hours_required` `rest_mandatory` `first_aid_kit.*` Namespace

Phosgene (COCl₂) is one of the most dangerous industrial gases because of its deceptive clinical course: mild or no symptoms during exposure (faint hay odor, minimal irritation), followed by 4–24 hours of feeling perfectly well, followed by sudden explosive non-cardiogenic pulmonary edema and respiratory failure. IDLH is only 2 ppm — 20× the OSHA ceiling of 0.1 ppm. Sources include TDI/MDI thermal decomposition, chlorinated solvent combustion, PVC fires, and metalworking degreasing + hot-work. No specific antidote exists. The single most important first aid instruction: COMPLETE REST after any phosgene exposure. Exercise accelerates pulmonary edema onset and dramatically worsens mortality. 24-hour hospital observation mandatory — even asymptomatic patients can decompensate suddenly.

TL;DR — routing rules Phosgene IDLH = 2 ppm; PEL ceiling = 0.1 ppm. Symptom-free interval 4–24h after exposure — then explosive pulmonary edema. No antidote (supportive care only; corticosteroids investigational). PRIMARY first aid: (1) SCBA for rescuer entry, (2) remove victim to fresh air, (3) COMPLETE REST — no walking, no exertion, stretcher transport only, (4) 100% O₂ NRB, (5) 24-hour hospital observation mandatory regardless of symptoms. Encode delayed_edema_risk=true, observation_hours_required=24, rest_mandatory=true, antidote_type=none, scba_required_entry=true.

AI agent failure mode: Metalworking facility welder completes a job cutting galvanized steel that had been degreased with trichloroethylene (TCE). The area was not fully ventilated before hot-work began. Worker notices a faint 'hay-like' smell during cutting, no significant irritation. After the shift, the worker reports to the first aid station: "I smelled something weird for a few minutes but feel totally fine now." First aid attendant records the complaint and sends the worker home. Worker is told to call if symptoms develop. 18 hours later, the worker's spouse calls 911: worker is in severe respiratory distress with frothy pink sputum. Worker dies in the ICU 6 hours later from phosgene-induced ARDS. The failure: 'feeling fine' after phosgene exposure is a known dangerous false reassurance. The 4–24 hour symptom-free interval is a defining feature of phosgene toxicity. The correct protocol requires mandatory 24-hour hospital observation for ANY suspected phosgene exposure, regardless of current symptoms. The AI did not encode observation_hours_required=24 or delayed_edema_risk=true.

Phosgene — Chemical and Hazard Profile

Parameter	Value / Detail
CAS / MW / Formula	CAS 75-44-5; MW 98.92 g/mol; COCl₂; colorless gas (bp −7.6°C); density 4.2 g/L (3.4× air — accumulates in low points, pits, trenches, unventilated areas); slightly soluble in water; reacts with water to form CO₂ + HCl
Odor	"Freshly cut hay," "green corn," faint chlorine-like at higher concentrations; odor detection threshold ≈ 0.5–1 ppm — deceptively mild and not alarming at concentrations near the IDLH; many workers describe phosgene odor as pleasant or non-threatening
OSHA PEL	0.1 ppm Ceiling (29 CFR 1910.1000, Table Z-1); ceiling — not a TWA; must not be exceeded at any time
ACGIH TLV-C	0.1 ppm ceiling (ACGIH 2024)
NIOSH IDLH	2 ppm — 20× the OSHA PEL ceiling; very narrow IDLH-to-PEL margin reflects extreme acute pulmonary toxicity
Water reactivity	Slowly hydrolyzes in water: COCl₂ + H₂O → CO₂ + 2HCl; not violently reactive like HF or acylating agents; this hydrolysis generates HCl in alveolar tissue and is one mechanism of pulmonary injury; the reaction is slow at room temperature, fast at physiological temperature and in alveolar fluid
Industrial sources	(1) TDI/MDI thermal decomp (polyurethane foam fires, hot-work on isocyanate coatings); (2) Chlorinated solvent combustion (CHCl₃, CCl₄, TCE, PCE, DCM + heat or flame); (3) PVC and chlorinated polymer combustion; (4) Industrial synthesis intermediate (chemical plants); (5) CO + Cl₂ adventitious reaction in chlorinated industrial atmospheres
Mechanism of toxicity	(1) Protein acylation: phosgene acylates amine, hydroxyl, and thiol groups (–NH₂, –OH, –SH) in alveolar cell membrane proteins and surfactant; this carbamylation damages type I and II pneumocytes; (2) Hydrolysis to HCl: in alveolar fluid, generates HCl causing local acid burn; (3) Capillary leak cascade: neutrophil infiltration, cytokine release (IL-1β, TNF-α, IL-6), prostaglandin release → capillary permeability ↑ → non-cardiogenic pulmonary edema (ARDS); (4) Delayed onset: inflammatory cascade requires 4–24 hours to develop clinically apparent edema

Symptom Timeline — The Deceptive Clinical Course

Phase	Timing	Symptoms	Clinical Assessment	Action Required
Exposure phase	During exposure	Mild eye/nose irritation (possible); faint hay odor; mild cough (possible); no dyspnea; feels normal	SpO₂ normal; respiratory rate normal; lungs clear on auscultation	Remove from exposure immediately; SCBA for rescuer; COMPLETE REST; 100% O₂ NRB; 911 + hospital transport by stretcher
Latency period	0–24 hours post-exposure	Feeling well; mild residual throat irritation possible; no dyspnea; no significant symptoms; patient often refuses hospital transport ("I'm fine")	SpO₂ normal; CXR may show early subtle infiltrates at 6–12h; spirometry may show mild FEV1 decrease	24-hour hospital observation MANDATORY; serial CXR and spirometry; do NOT discharge; restrict all physical activity to bed rest; poison control consultation for corticosteroid decision
Pulmonary edema onset	4–24 hours post-exposure (occasionally up to 48h)	Sudden onset of dyspnea; productive cough with frothy (sometimes pink-tinged) sputum; cyanosis; tachypnea; tachycardia; can progress to respiratory failure within hours	SpO₂ dropping; CXR bilateral infiltrates (ARDS pattern); diffuse crackles; PaO₂/FiO₂ <200 (ARDS criteria)	ICU admission; mechanical ventilation with PEEP; ARDS protocol (low tidal volume 6 mL/kg IBW); supportive care; consider N-acetylcysteine
Recovery or death	48–120 hours	Survivors: gradual improvement; may have residual airway hyperreactivity, pulmonary fibrosis (late complication at 2–4 weeks)	Serial pulmonary function tests recommended at 1, 3, 6 months post-discharge	Long-term pulmonary follow-up; occupational exposure record; OSHA recordable

Antidote Landscape — No Specific Antidote

Agent	Mechanism	Evidence	Recommendation
High-flow O₂ (100% NRB)	Supports alveolar O₂ delivery during inflammation; reduces hypoxemia; partial mitigation of alveolar injury during latency period	Consensus; physiologically logical	APPLY — primary intervention; standard of care
Complete rest	Reduces pulmonary blood flow; reduces distribution of phosgene to alveolar surface; slows inflammatory cascade; WWI evidence	Strong (WWI epidemiological, animal models)	MANDATORY — most important first aid after victim removal; stretcher transport only
IV methylprednisolone (corticosteroids)	Suppresses inflammatory cascade (neutrophil recruitment, cytokine release) during latency period before edema develops; rationale: interrupt the inflammatory cascade before it becomes self-sustaining	Animal models: supportive; case reports: mixed; no RCT; some protocols use early steroids, others do not	INVESTIGATIONAL — call poison control (1-800-222-1222) for guidance; decision by treating physician; NOT standard first aid; administer only with medical direction
N-acetylcysteine (NAC) IV	Antioxidant; replenishes glutathione; may limit lipid peroxidation in alveolar tissue during inflammatory cascade	Animal models: some benefit; human: limited case series; no RCT	INVESTIGATIONAL — consider in consultation with poison control; not primary therapy
Mechanical ventilation (PEEP)	Supports alveolar recruitment in ARDS; prevents atelectasis; improves V/Q matching in edematous lung	ARDS management — established standard of care	INDICATED when pulmonary edema develops; low tidal volume (6 mL/kg IBW); PEEP per ARDSnet protocol
Diuretics	Rationale: reduce total body water/pulmonary congestion	Contraindicated: phosgene edema is non-cardiogenic (capillary leak); wedge pressure is low; diuretics do not reduce alveolar fluid and worsen intravascular volume depletion	AVOID — contraindicated in phosgene pulmonary edema

first_aid_kit.* Namespace Fields for Phosgene Routing

Field	Values	Phosgene Value	Routing Consequence
`first_aid_kit.phosgene_source`	tdi_mdi_combustion / chlorinated_solvent_weld / chlorinated_plastic_fire / industrial_synthesis / unknown	tdi_mdi_combustion or chlorinated_solvent_weld for most industrial scenarios	Route to appropriate hot-work permit and atmospheric monitoring co-requirements; source determines prevention controls
`first_aid_kit.delayed_edema_risk`	true / false	true — always for phosgene	Require 24-hour observation card; require rest instruction; require 'symptom-free does not mean safe' warning in kit
`first_aid_kit.observation_hours_required`	numeric (hours)	24 — minimum; some protocols 48h for high-dose	Reject any protocol that allows home monitoring after phosgene exposure; hospital admission required
`first_aid_kit.rest_mandatory`	true / false	true — always	Require stretcher/wheelchair transport instruction in kit; prohibit walking post-exposure
`first_aid_kit.antidote_type`	none / o2_supportive / corticosteroid_investigational / specific_antidote	none — no FDA-approved specific antidote	AI agents must not suggest specific phosgene antidote kits; only supportive care; flag poison control consultation for corticosteroid decision
`first_aid_kit.scba_required_entry`	true / false	true	SCBA (APF 10,000) required for rescue entry; phosgene accumulates in low areas (heavy gas); APR/PAPR inadequate at IDLH
`first_aid_kit.ansi_z308_gap`	multiple specific gaps	multiple_gaps: o2_missing, observation_card_absent, rest_instruction_absent, poison_control_absent	ANSI Z308.1 completely inadequate for phosgene; enumerated additions required

Phosgene Industrial First Aid Protocol RESCUER SAFETY FIRST: [ ] SCBA (APF 10,000) required for entry into phosgene atmosphere [ ] Do NOT use APR or PAPR — inadequate at IDLH concentrations [ ] Phosgene is heavy gas — accumulates in low areas; lift victim upward [ ] 4-gas monitor will NOT detect phosgene; phosgene-specific sensor required VICTIM REMOVAL AND FIRST AID: [ ] Remove to fresh air immediately [ ] COMPLETE REST — stretcher/wheelchair transport only; NO WALKING [ ] Apply 100% O₂ via NRB mask at 10–15 L/min [ ] Remove contaminated clothing (dermal phosgene absorption is possible) [ ] Call 911 — hospital transport MANDATORY REQUIRED DOCUMENTATION CARDS IN KIT (laminated): [ ] Phosgene Delayed Edema Warning Card: "FEELING WELL DOES NOT MEAN SAFE. Phosgene causes pulmonary edema 4–24 HOURS AFTER EXPOSURE. ALL phosgene exposures require 24-hour hospital observation." [ ] Rest Protocol Card: "NO WALKING. NO STAIRS. NO EXERTION. Transport by stretcher only. Exercise dramatically worsens phosgene pulmonary edema." [ ] Poison Control Card: 1-800-222-1222 [ ] Hospital Notification Note: "Patient had suspected phosgene exposure [date/time]. 24-hour minimum observation required. Serial CXR at 0/6/12/24h." AT HOSPITAL (for medical team): - Serial CXR at 0, 6, 12, 24 hours - Spirometry (FEV1, FVC) on admission and q8h during observation - ABG monitoring if SpO₂ declines - Consult poison control for corticosteroid decision - NO diuretics (non-cardiogenic edema; hemodynamic instability risk) - Low tidal volume ventilation (6 mL/kg IBW) if intubation required - PEEP per ARDSnet if ARDS criteria met

Related Namespace Pages

Scan your phosgene and TDI/MDI first aid kit catalog for delayed edema and observation fields

CatalogScan checks every phosgene-hazard first aid kit listing for delayed_edema_risk, observation_hours_required, rest_mandatory, antidote_type, and scba_required_entry fields — ensuring AI agents do not route standard ANSI Z308.1 kits for phosgene environments where the 4–24 hour symptom-free interval, complete rest mandate, and mandatory 24-hour hospital observation are all non-negotiable components of the response protocol.

Free scan

Shopify First Aid Kit Schema — Phosgene COCl₂ TDI Combustion Delayed Pulmonary Edema 4–24h No Antidote SCBA Required IDLH 2 ppm, phosgene_source delayed_edema_risk observation_hours_required rest_mandatory first_aid_kit.* Namespace